Recent advances in the treatment of colon cancer

Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Although surgical resection is still the only treatment capable of curing colon cancer, adjuvant therapy continues to play an important role in preventing recurrence and metastasis. In recent years remarkable progress has been made in the treatment of colon cancer. This review discusses recent advances in adjuvant therapy for colon cancer, including chemotherapy, immunotherapy, antiangiogenic therapy and apoptosis induction. In the meantime, molecular therapy is also elucidated in the above methods. All these new advances will provide new promises for patients of colon cancer.     

云南萝芙木pnae基因全长克隆及其序列分析

根据已知的其他物种PNAE酶cDNA序列设计引物,采用RT-PCR技术从云南萝芙木叶片中扩增获得pnae基因部分cDNA序列即PNAE酶基因中间大片段,再用RACE技术获得其两端序列。序列拼接得到完整的1 004 bp的PNAE酶基因,根据获得的序列,分析得到795 bp的开放阅读框,编码264个氨基酸。序列分析显示,云南萝芙木中PNAE酶氨基酸序列与蛇根木中的该酶氨基酸序列同源性高达90%,但和其他植物物种中的PNAE酶氨基酸序列,以及其他物种间的PNAE酶氨基酸序列同源性都不高,在40%-60%之间,表明不同物种中PNAE酶氨基酸序列不具有全序列的高度同源性。进一步序列分析发现,在各植物的PNAE酶氨基酸序列中都存在两个高度保守的氨基酸区域,表明不同物种中PNAE酶存在共同的高度保守区段。     

Effects of acorn masting on population dynamics of three forest-dwelling rodent species in Hokkaido,Japan

The effects of the abundance of acorns of the oak, Quercus crispula, on the population dynamics of three rodent species (Apodemus speciosus, A. argenteus, and Clethrionomys rufocanus) were analyzed using time series data (1992–2006). The data were obtained in a forest in northern Hokkaido, Japan, by live trapping rodents and directly counting acorns on the ground. Apodemus speciosus generally increased in abundance following acorn masting. However, the clear effect of acorn abundance was not detected for the other two rodent species. Acorns of Q. crispula contain tannins, which potentially have detrimental effects on herbivores. Apodemus speciosus may reduce the damage caused by acorn tannins with tannin-binding salivary proteins and tannase-producing bacteria, whereas such physiological tolerance to tannins is not known in the other two rodent species. The differences in the effects of acorns between the three species may be due to differences in their physiological tolerance to tannins.     

Strategic mining of cyanobacterial patents from the USPTO patent database and analysis of their scope and implications

Patent analysis with the help of the strategic mining of patents from databases is important and useful within the framework of application-oriented research and its commercialization. In the analysis reported here, we have mined cyanobacterial patents from the patent database of the United States Patent and Trademark Office (USPTO). In order to make an assessment of the commercial potentials of cyanobacteria, we conducted the patent search (from 1976 to April 2006) using certain generic terms and the 84 genera of cyanobacteria as keywords. The search was performed in two major ways – searching the abstracts and claims of the patents cumulatively and searching the entire patent documents by the mode of ‘all fields’ in USPTO. In the abstract- and claims-based search, 234 patents were obtained after the removal of overlapping patents among the keywords. An additional 31 patents were added following the ‘all fields’ search; these patents were not covered in the search that was based on abstracts and claims. The entire package of 265 patents, of which 244 were related to cyanobacteria, was then analyzed. Information derived from these patents identified five major areas of cyanobacterial utilization. Cyanobacteria have been patented as a source of a wide spectrum of products, for medical, agriculture and environmental applications, for gene-based products, for methods of cultivation and for methods of control. The chronological development in granting cyanobacterial patents was also traced. This study demonstrates that such strategic mining and analysis of patent data can be used as an index for future development.     

Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1

The current treatment strategies, chemotherapy and radiation therapy being used for the management of cancer are deficient in targeted approach leading to treatment related toxicities and relapse. Contrarily, fusion toxins exhibit remarkable tumor specificity thus emerging as an alternative therapy for the treatment of cancer. Diphtheria toxin-HN-1 peptide (DT/HN-1) is a fusion toxin designed to target the head and neck squamous cell carcinoma (HNSCC). The aim of this study was to construct, characterize, and evaluate the cytotoxicity and specificity of DT/HN-1 fusion toxin against the HNSCC cells. The purified DT/HN-1 fusion toxin was characterized by SDS-PAGE and western blotting. Refolding of purified fusion toxins was monitored by fluorescence spectra and circular dichroism spectra. The activity of DT/HN-1 fusion toxin was demonstrated on various HNSCC cell lines by cell viability assay, cell proliferation assay, protein synthesis inhibition assay, apoptosis and cell cycle analysis. The fusion toxin DT/HN-1 demonstrated remarkably high degree of cytotoxicity specific to the HNSCC cells. The IC₅₀ of DT/HN-1 fusion toxin was ~1 to 5 nM in all the three HNSCC cell lines. The percentage apoptotic cells in DT/HN-1 treated UMB-SCC-745 cells are 16% compared to 4% in untreated. To further demonstrate the specific toxicity of DT/HN-1 fusion toxin towards the HNSCC cells we constructed, characterized and evaluated the efficacy of DT protein. The DT protein coding for only a fragment of diphtheria toxin without its native receptor binding domain failed to exhibit any cytotoxicity on all the cell lines used in this study thus establishing the importance of a ligand in achieving targeted toxicity. To evaluate the translocation ability of HN-1 peptide, an additional construct DTΔT/HN-1 was constructed, characterized and evaluated for its cytotoxic activity. The fusion toxin DTΔT/HN-1 deficient of the translocation domain of diphtheria toxin showed no cytotoxicity on all the cell lines clearly indicating the inability of HN-1 peptide to translocate catalytic domain of the toxin into the cytosol.     

siRNA干扰HIF-1α表达对高糖高胰岛素诱导的肥大心肌细胞的影响

目的 研究胰岛素受体底物1(insulin receptor substrate 1,IRS1)和缺氧诱导因子1a(hypoxia inducible factor 1a,HIF-1a)在高糖高胰岛素诱导的肥大心肌细胞中的表达及其之间的关系;观察siRNA沉默HIF-1a基因对高糖高胰岛素诱导的心肌细胞肥大的影响.方法 新生大鼠心肌细胞培养48h后,换用无血清DMEM培养液并分别加入高糖高胰岛素、高糖高胰岛素+HIF-1a-siRNA培养48h,未加入任何药物的心肌细胞在无血清DMEM培养液中继续培养48h作为对照.通过心肌细胞表面积、总蛋白含量指标检测心肌细胞肥大,并利用Real time PCR检测转染前后HIF-1a mRNA表达变化及免疫细胞化学方法检测HIF-1a及IRS1蛋白水平的表达.结果 高糖高胰岛素可增加心肌细胞表面积、总蛋白含量、HIF-1a mRNA以及HIF-1a表达,并降低IRS1表达.转染siRNA后使HIF-1a基因的表达下降,能部分抑制心肌细胞的肥大,降低心肌细胞表面积和总蛋白含量,但对IRS1表达的影响不明显.在对正常对照组和高糖高胰岛素组中IRS1表达量与HIF-1a表达量进行相关分析表明,两者的表达量成负相关.结论 通过siRNA技术对HIF-1a的有效沉默可明显地抑制高糖高胰岛素诱导大鼠乳鼠心肌细胞肥大,并且这种作用可能是通过作用于IRS1/PI3K/ Akt/MTOR途径来实现的.     

生命伦理学视野下的转基因作物产业化问题研究

转基因作物的产业化作为当前生命伦理学的重要问题之一日益受到我国学术界、政府和广大公众的关注。转基因作物产业化不仅关涉到我国13亿人的吃饭问题,也与我国公众的身心健康、基本权利密切相关。转基因作物产业化的生命伦理意蕴主要体现在：转基因作物产业化的基础是确保公众健康与生命安全,关键是尊重公众权利,核心是促进社会公正。     

Secretory delivery of heterologous proteins in attenuated <Emphasis Type="Italic">Vibrio anguillarum</Emphasis> for potential use in vaccine design

To synthesize and secrete heterologous proteins in an attenuated Vibrio anguillarum strain for potential multivalent live vaccine development, different antigen-delivery systems based on bacterial-originated secretion signal peptides (SPs) were designed and identified in this work. Four SPs were derived from hemolysin of Escherichia coli, RTX protein of V. cholerae, hemolysin of V. anguillarum, zinc-metalloprotease of V. anguillarum, respectively, and their abilities to support secretion of green fluorescent protein (GFP) in an attenuated V. anguillarum strain MVAV6203 were assayed. Immunodetection of GFP showed that the capability of the tested signal leaders to direct secretion of GFP varied greatly. Although all the four signal peptide-fused GFPs could be expressed correctly and trapped intracellularly in recombinant strains, only the EmpA signal peptide could confer efficient secretion to GFP. For the investigation of its potential application in live bacteria carrier vaccines, a heterologous protein EseB of Edwardsiella tarda was fused to the SP(empA) antigen-delivery system and introduced into the strain MVAV6203. Further analysis of EseB demonstrated that the constructed SP(empA) antigen-delivery system could be used to secrete foreign protein in attenuated V. anguillarum and be available for carrier vaccines development.